We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
P&G (PG) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Read MoreHide Full Article
The upcoming report from Procter & Gamble (PG - Free Report) is expected to reveal quarterly earnings of $1.89 per share, indicating a decline of 5% compared to the year-ago period. Analysts forecast revenues of $22.7 billion, representing an increase of 1.4% year over year.
The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
With that in mind, let's delve into the average projections of some P&G metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus among analysts is that 'Net Sales- Beauty' will reach $4.31 billion. The estimate indicates a change of +4% from the prior-year quarter.
Analysts forecast 'Net Sales- Grooming' to reach $1.83 billion. The estimate points to a change of +0.5% from the year-ago quarter.
The average prediction of analysts places 'Net Sales- Corporate' at $242.87 million. The estimate indicates a change of +0.4% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Fabric & Home Care' of $7.93 billion. The estimate suggests a change of +1.7% year over year.
Analysts' assessment points toward 'Net Sales- Baby, Feminine & Family Care' reaching $5.16 billion. The estimate indicates a year-over-year change of -0.2%.
It is projected by analysts that the 'Net Sales- Health Care' will reach $3.27 billion. The estimate indicates a change of +1.5% from the prior-year quarter.
Analysts predict that the 'Organic Sales Growth (YoY change) - Beauty' will reach 3.8%. Compared to the current estimate, the company reported 6.0% in the same quarter of the previous year.
The consensus estimate for 'Organic Sales Growth (YoY change) - Grooming' stands at 0.5%. The estimate compares to the year-ago value of 3.0%.
The combined assessment of analysts suggests that 'Earnings before income taxes- Beauty' will likely reach $1.08 billion. The estimate is in contrast to the year-ago figure of $1.13 billion.
Analysts expect 'Earnings before income taxes- Grooming' to come in at $546.79 million. The estimate is in contrast to the year-ago figure of $585.00 million.
According to the collective judgment of analysts, 'Earnings before income taxes- Health Care' should come in at $927.58 million. Compared to the present estimate, the company reported $937.00 million in the same quarter last year.
Based on the collective assessment of analysts, 'Earnings before income taxes- Fabric & Home Care' should arrive at $1.99 billion. The estimate compares to the year-ago value of $2.04 billion.
P&G shares have witnessed a change of +8.9% in the past month, in contrast to the Zacks S&P 500 composite's +1.5% move. With a Zacks Rank #3 (Hold), PG is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
P&G (PG) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
The upcoming report from Procter & Gamble (PG - Free Report) is expected to reveal quarterly earnings of $1.89 per share, indicating a decline of 5% compared to the year-ago period. Analysts forecast revenues of $22.7 billion, representing an increase of 1.4% year over year.
The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
With that in mind, let's delve into the average projections of some P&G metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus among analysts is that 'Net Sales- Beauty' will reach $4.31 billion. The estimate indicates a change of +4% from the prior-year quarter.
Analysts forecast 'Net Sales- Grooming' to reach $1.83 billion. The estimate points to a change of +0.5% from the year-ago quarter.
The average prediction of analysts places 'Net Sales- Corporate' at $242.87 million. The estimate indicates a change of +0.4% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Net Sales- Fabric & Home Care' of $7.93 billion. The estimate suggests a change of +1.7% year over year.
Analysts' assessment points toward 'Net Sales- Baby, Feminine & Family Care' reaching $5.16 billion. The estimate indicates a year-over-year change of -0.2%.
It is projected by analysts that the 'Net Sales- Health Care' will reach $3.27 billion. The estimate indicates a change of +1.5% from the prior-year quarter.
Analysts predict that the 'Organic Sales Growth (YoY change) - Beauty' will reach 3.8%. Compared to the current estimate, the company reported 6.0% in the same quarter of the previous year.
The consensus estimate for 'Organic Sales Growth (YoY change) - Grooming' stands at 0.5%. The estimate compares to the year-ago value of 3.0%.
The combined assessment of analysts suggests that 'Earnings before income taxes- Beauty' will likely reach $1.08 billion. The estimate is in contrast to the year-ago figure of $1.13 billion.
Analysts expect 'Earnings before income taxes- Grooming' to come in at $546.79 million. The estimate is in contrast to the year-ago figure of $585.00 million.
According to the collective judgment of analysts, 'Earnings before income taxes- Health Care' should come in at $927.58 million. Compared to the present estimate, the company reported $937.00 million in the same quarter last year.
Based on the collective assessment of analysts, 'Earnings before income taxes- Fabric & Home Care' should arrive at $1.99 billion. The estimate compares to the year-ago value of $2.04 billion.
View all Key Company Metrics for P&G here>>>P&G shares have witnessed a change of +8.9% in the past month, in contrast to the Zacks S&P 500 composite's +1.5% move. With a Zacks Rank #3 (Hold), PG is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .